Live feed/
Filings
/
SCHEDULE
/
0000902664-25-001335
Stake: 19.99%
Shares: 11,914,961
CUSIP: 00032Q104
Class: Common stock, par value $0.0001 per share
Item 4 — Purpose of Transaction
On February 28, 2025, the Issuer obtained the Required Stockholder Approval for the 2024 PIPE Financing. The 2024 PIPE Financing closed on March 4, 2025, pursuant to which Avoro Life Sciences acquired Pre-Funded Warrants to purchase 6,666,400 shares of Common Stock and Avoro Ventures Fund acquired 3,999,673 shares of Common Stock.
Cross-References
Insider Activity (last 365d)
2 transactions
0 buys · 2 sales · 0 awards/exercises
Issuer Cluster
23 13D/G filings on this issuer
22 other filings besides this one
Filer Track Record
7 filings by this filer
6 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 7.57
4,179,811 shares short · +47.5% vs prior
Post-Filing Returns · since 2025-02-28 on WHWK
Anchor price 4.15 on closest trading day on/after 2025-02-28. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
Form 4 Insider Transactions · last 365d
| Date | Insider | Role | Type | Shares | Price | Value |
|---|
| 2026-04-14 |
BALL BRYAN |
officer |
Sale |
92,460 |
$3.64 |
$337K |
| 2026-04-13 |
BALL BRYAN |
officer |
Sale |
26,389 |
$3.46 |
$91K |
Other 13D/G Filings on Aadi Bioscience, Inc.
| Filed | Form | Filer | Stake | Shares | |
|---|
| 2026-05-18 |
SCHEDULE 13D/A |
ACUTA CAPITAL PARTNERS, LLC |
9.00% |
4,685,912 |
view → |
| 2026-05-14 |
SCHEDULE 13D/A |
Avoro Capital Advisors LLC |
— |
15,893,516 |
view → |
| 2025-03-06 |
SCHEDULE |
Desai Neil |
4.90% |
2,272,941 |
view → |
| 2025-03-05 |
SCHEDULE |
BML Investment Partners, L.P. |
4.98% |
2,435,000 |
view → |
| 2025-02-24 |
SCHEDULE |
BML Investment Partners, L.P. |
9.90% |
2,435,000 |
view → |
| 2025-02-04 |
SCHEDULE |
BML Investment Partners, L.P. |
9.90% |
2,435,000 |
view → |
| 2025-01-24 |
SCHEDULE |
ACUTA CAPITAL PARTNERS, LLC |
7.80% |
1,921,297 |
view → |
| 2024-10-01 |
SC |
Desai Neil |
— |
— |
view → |
| 2022-09-26 |
SC |
Avoro Capital Advisors LLC |
— |
— |
view → |
| 2021-11-12 |
SC |
Satter Muneer A |
— |
— |
view → |
| 2021-09-03 |
SC |
ORBIMED ADVISORS LLC |
— |
— |
view → |
| 2021-08-30 |
SC |
Avoro Capital Advisors LLC |
— |
— |
view → |
| 2020-11-23 |
SC |
Satter Muneer A |
— |
— |
view → |
| 2020-11-12 |
SC |
ORBIMED ADVISORS LLC |
— |
— |
view → |
| 2020-05-15 |
SC |
Novartis Bioventures Ltd |
— |
— |
view → |
| 2020-04-22 |
SC |
Novartis Bioventures Ltd |
— |
— |
view → |
| 2019-06-07 |
SC |
Novartis Bioventures Ltd |
— |
— |
view → |
| 2019-04-29 |
SC |
Novartis Bioventures Ltd |
— |
— |
view → |
| 2019-01-11 |
SC |
Satter Muneer A |
— |
— |
view → |
| 2018-07-09 |
SC |
Novartis Bioventures Ltd |
— |
— |
view → |
Showing 20 of 22
Other Filings by Avoro Capital Advisors LLC
| Filed | Form | Issuer | Stake | Shares | |
|---|
| 2026-07-30 |
SCHEDULE 13D |
Scribe Therapeutics, Inc. |
16.37% |
2,598,973 |
view → |
| 2026-05-14 |
SCHEDULE 13D/A |
Whitehawk Therapeutics, Inc. WHWK |
— |
15,893,516 |
view → |
| 2022-09-26 |
SC |
Aadi Bioscience, Inc. WHWK |
— |
— |
view → |
| 2021-11-24 |
SC |
ACCELERON PHARMA INC |
— |
— |
view → |
| 2021-08-30 |
SC |
Aadi Bioscience, Inc. WHWK |
— |
— |
view → |
| 2020-10-23 |
SC |
IMMUNOMEDICS INC |
— |
— |
view → |
Want this depth on every filing the moment it hits SEC EDGAR?
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →